Medical Device News Magazine

AI that Overcomes the Image Integrity Challenge

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

In just the last twelve months, there has been a wave of hype around artificial intelligence (AI) image generation tools. DALLE-E, Midjourney, and Stable Diffusion have brought joy to many users, who can create novel images from just a few words. In science, as in art, AI tools are also changing the way things are done. Here Dr. Dror Kolodkin-Gal, founder of Proofig, explores how AI is changing the image integrity landscape.

Research from Morten P. Oksvold found that 25 per cent of all life science articles published may contain duplicatedor manipulated images. Many of these duplications are not the result of fraudulent research, but honest mistakes.


It is important we reduce this, to protect the accuracy of the scientific literature. However, a single paper could contain hundreds of sub images, and checking them manually can be time consuming, as well as carry low probability that the researcher will identify all of the issues, which are hard to spot with the human eye and may require hundreds or thousands of comparisons per paper.

With journal editors under increasing pressure, there is similarly low probability the issues will be detected at peer review. In many cases, they are picked up post-publicationand result in investigation and potential retraction or erratum, putting reputations of researchers, journals, and even science itself, at risk.

Overcoming image integrity issues

To address this challenge, we launched Proofig, an automated image duplication and manipulation tool that can be used by researchers and journal editors alike. Thissoftware carries out a range of checks so they can be addressed before publication. It can detect full duplications (include scaling or rotating), partial duplication or overlapping, alongside flipped images, figure manipulations, copy and paste, cloning and any of these issues combined. Each image is compared with itself (for internal duplications) and with all others (for image issues as described), as well as comparing each flipped image with the other images within the uploaded files.

Professor Ofer Mandelboim, head of the department of immunology and cancer research at Hebrew University Faculty of Medicine, Israel said: I’m happy to provide my department with the peace of mind that comes with knowing our manuscripts’ images have been properly verified pre-publication using Proofig, and only manuscripts with no mistakes will follow for publication.

Proofig is increasingly being adopted by publishers as part of the review process. For example, the American Association for Cancer Research (AACR) found that checking for duplication using Proofig took 4.4 minutes compared with eight minutes manually, and identifiedeleven duplications in eight manuscripts, compared with five duplications in three manuscripts manually.

As AI-based image software for art continues to gain traction, AI tools are also advancing the scientific industry. By adopting this approach, publishing houses, universities, and authors can help maintain the integrity of the scientific literature and prevent harm to the field of science itself through enhanced quality control.

Do you want to learn more about the benefits of AI tools for maintaining image integrity? Find out more about Proofig and try the software yourself by visiting us at https://www.proofig.com.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”